We found that TF expression in breast cancer lines and tumors closely clustered with higher levels of EMT (high vimentin/low E-cadherin) and classical basal-type biomarkers KRT5, KRT14 and caveolin-1, while it clustered with lower levels luminal-type biomarkers KRT8, KRT18, ERBB3 and ESR1. This evidence concerns the gene KRT18 and breast carcinoma.